Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.
about
Adolescent Scalp Psoriasis: Update on Topical Combination TherapyA Comprehensive Review of Clocortolone Pivalate 0.1% Cream: Structural Development, Formulation Characteristics, and Studies Supporting Treatment of Corticosteroid-responsive DermatosesUnder-Treatment of Patients with Moderate to Severe Psoriasis in the United States: Analysis of Medication Usage with Health Plan DataDiagnosis and management of psoriasis.Diagnostic et prise en charge du psoriasisCalcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study.Use of Topical Coal Tar Foam for the Treatment of Psoriasis in Difficult-to-treat Areas.The rationale behind topical vitamin d analogs in the treatment of psoriasis: where does topical calcitriol fit in?Methotrexate vs. fumaric acid esters in moderate-to-severe chronic plaque psoriasis: data registry report on the efficacy under daily life conditions.Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.Ultraviolet Phototherapy Management of Moderate-to-Severe Plaque Psoriasis: An Evidence-Based Analysis.A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment and Maintenance of Psoriasis.Calcipotriene/betamethasone in the treatment of psoriasis: a review article.Oral granulated Chinese herbal medicine (YXBCM01) plus topical calcipotriol for psoriasis vulgaris: study protocol for a double-blind, randomized placebo controlled trial.Efficacy of an innovative aerosol foam formulation of fixed combination calcipotriol plus betamethasone dipropionate in patients with psoriasis vulgaris.Safety and efficacy of calcipotriene plus betamethasone dipropionate topical suspension in the treatment of extensive scalp psoriasis in adolescents ages 12 to 17 years.Liposomal fusidic acid as a potential delivery system: a new paradigm in the treatment of chronic plaque psoriasis.Impact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3µg/g in Patients with Mild-to-moderate Plaque Psoriasis.Apremilast (Otezla): A New Oral Treatment for Adults With Psoriasis and Psoriatic Arthritis.Streptavidin suppresses T cell activation and inhibits IL-2 production and CD25 expressionA multicenter, randomized, open-label pilot trial assessing the efficacy and safety of etanercept 50 mg twice weekly followed by etanercept 25 mg twice weekly, the combination of etanercept 25 mg twice weekly and acitretin, and acitretin alone in paTreatment of plaque psoriasis with an ointment formulation of the Janus kinase inhibitor, tofacitinib: a Phase 2b randomized clinical trial.An Applicator Delivery System for Fixed-Combination Calcipotriene Plus Betamethasone Dipropionate Topical Suspension (Gel): Innovating Psoriasis Vulgaris Treatment Through Patient CollaborationMechanisms of action of topical corticosteroids in psoriasisProviding Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.Fixed Combination Aerosol Foam Calcipotriene 0.005% (Cal) Plus Betamethasone Dipropionate 0.064% (BD) is More Efficacious than Cal or BD Aerosol Foam Alone for Psoriasis Vulgaris: A Randomized, Double-blind, Multicenter, Three-arm, Phase 2 Study.Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris--A randomized phase II study.Patient Preferences for Topical Psoriasis Treatments are Diverse and Difficult to Predict.Cutaneous Adverse Events in the Randomized, Double-Blind, Active-Comparator DECIDE Study of Daclizumab High-Yield Process Versus Intramuscular Interferon Beta-1a in Relapsing-Remitting Multiple SclerosisSupersaturation of Calcipotriene and Betamethasone Dipropionate in a Novel Aerosol Foam Formulation for Topical Treatment of Psoriasis Provides Enhanced Bioavailability of the Active Ingredients.Real-life effectiveness of once-daily calcipotriol and betamethasone dipropionate gel vs. ointment formulations in psoriasis vulgaris: final analysis of the 52-week PRO-long studyUpdates on Psoriasis and Cutaneous Oncology: Proceedings from the 2016 MauiDerm Meeting based on presentations by.Topical nicotinamide in combination with calcipotriol for the treatment of mild to moderate psoriasis: A double-blind, randomized, comparative study.Efficacy and Safety of Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam Compared with Betamethasone 17-Valerate-Medicated Plaster for the Treatment of Psoriasis.Topical treatment of psoriasis.How genetic variation affects patient response and outcome to therapy for psoriasis.Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris of the trunk, limbs and scalp.In touch with psoriasis: topical treatments and current guidelines.Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.Acrodermatitis continua of Hallopeau: evolution of treatment options.
P2860
Q26800230-06D8EF9F-5B4D-42F6-AFDD-8B854BC7B368Q28271214-DD3E6660-31E9-4A19-A7FA-5810604D9F62Q31146263-8698BC26-1E0A-4FD0-9A87-0ABDB2E0F032Q33558495-3C4986B3-BB17-4437-B78D-BED51C0C61A5Q33558550-BEE5F0A2-B531-47B1-A49A-FB6CF40A6659Q33650112-AA02F897-44B5-4C05-9D7D-73DC9A46ABC2Q34140609-02105687-AB1D-4C5D-AEA2-D4EB409EE605Q34156429-8AEC8343-AF75-463B-BEC6-ECF163C3D4A8Q34294189-4591EF04-07F6-4CF6-A3FB-75C9D44CF5E6Q34412891-4C03A4DB-8083-4D79-B1DD-07AF999E2907Q34449302-BFA574FD-ADB9-4BED-BD63-BCB34206E2B7Q34632467-7C837D4F-0245-44D2-897E-A2DD7C844DA8Q34996165-5FD8B4EB-607B-45CD-AE13-7D1A61B9AC45Q34996214-EDBF4F60-6EB8-414D-8F56-583DECC87C1EQ35203542-A39E1199-5D6E-43EF-A5AA-5DF30AFC7E08Q35817223-D591A787-D3AF-46CE-B343-555DD8A27A51Q35848232-1AEA61E3-7A6C-47A7-8E1B-A66D015BEDA4Q35862134-F9D15CD3-7C9C-4D43-BF0B-979A78991734Q35896444-0A5D7181-C503-417A-9461-FF09CF5283F2Q35923263-CF854E61-D00C-4A7E-A938-454333400274Q36085078-85C9AB13-8240-4A91-8377-9DAD13AECF96Q36157003-40487AC6-7BCB-4BA6-BD71-1F76D17F111EQ36360014-CC3C41F2-8DFB-406E-BA24-0F41313D0814Q36429698-387B7A2A-67C8-42DE-AAD8-EBB8C54E0760Q36628064-DD2355B3-D46B-4F03-AFD1-6E2FA55D6572Q36631474-9F1EF968-70A8-4403-9259-32AE83F8AA09Q36635181-E335E588-A316-47F1-8206-CFCA851DF6B4Q36999996-7D3F75E8-8F27-4CC5-853E-188DD9D382EFQ37080630-9AC29250-362E-4311-89CA-510E19DEAF3FQ37150168-B57A4146-0897-40D6-97A4-373342099075Q37309074-BE156831-B20B-4C07-90C2-8183BA1C42B7Q37362082-79391267-B53A-456F-9BC9-0EBE189310F7Q37536855-6285F369-12F8-4DAC-8198-3862F2908935Q37693862-6E74205F-40E7-4C1D-9B71-E495BD0B3122Q37766897-F64A7EAC-B6D2-4A2F-8838-03ED89E4C554Q37803415-7CF71115-B6D7-4A70-BB54-E54022BF029EQ37866759-20E1ED43-B8E2-45D3-9994-705C827EF2E6Q37867171-23C0EC62-7B1A-4271-A78E-1130092BA248Q37874681-AD78BBE8-0228-4091-826F-C2F227896F78Q37939197-55D5A55F-FA81-4B51-B9DB-44F6FF8A2634
P2860
Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies.
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Guidelines of care for the man ...... riasis with topical therapies.
@ast
Guidelines of care for the man ...... riasis with topical therapies.
@en
Guidelines of care for the man ...... riasis with topical therapies.
@nl
type
label
Guidelines of care for the man ...... riasis with topical therapies.
@ast
Guidelines of care for the man ...... riasis with topical therapies.
@en
Guidelines of care for the man ...... riasis with topical therapies.
@nl
prefLabel
Guidelines of care for the man ...... riasis with topical therapies.
@ast
Guidelines of care for the man ...... riasis with topical therapies.
@en
Guidelines of care for the man ...... riasis with topical therapies.
@nl
P2093
P1476
Guidelines of care for the man ...... riasis with topical therapies.
@en
P2093
Abby S Van Voorhees
Alan Menter
Alice Gottlieb
American Academy of Dermatology
Craig A Elmets
Henry W Lim
Joel M Gelfand
John Y M Koo
Karl R Beutner
Kenneth B Gordon
P304
P356
10.1016/J.JAAD.2008.12.032
P407
P577
2009-02-13T00:00:00Z